BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Buy Rating With a Price Target of $14.00 From CB Capital Partners

  March 5, 2025

   · 

  6 min read
• Press Releases

  Elegen Cuts Pricing for ENFINIA™ DNA, Expanding Access to Next-Generation Cell-Free DNA Manufacturing

  March 5, 2025

   · 

  2 min read
• Press Releases

  Verisma Welcomes Two New Board Members to Propel Strategic Growth

  March 5, 2025

   · 

  3 min read
• Press Releases

  Tenax Therapeutics Announces $25 Million Private Placement

  March 5, 2025

   · 

  3 min read
• Press Releases

  Sofwave Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

  March 5, 2025

   · 

  4 min read
• Press Releases

  Tenax Therapeutics Expands Phase 3 LEVEL Program, Advancing Two TNX-103 (Oral Levosimendan) Registrational Studies for the Treatment of PH-HFpEF

  March 5, 2025

   · 

  7 min read
• Press Releases

  Lisata Therapeutics and GATC Health Consummate First Step in Strategic Collaboration to use AI to Derisk and Accelerate Drug Development

  March 5, 2025

   · 

  10 min read
• Press Releases

  Momentum Biotechnologies Announces Acquisition of OmicScouts

  March 5, 2025

   · 

  4 min read
• Press Releases

  Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBI-1140675, a Second-Generation VMAT2 Inhibitor, in Healthy Adults

  March 5, 2025

   · 

  4 min read
• Press Releases

  Ensysce Biosciences to Participate in the 37th Annual ROTH Conference

  March 5, 2025

   · 

  1 min read